There are weeks when it seems like papers on stem cells keep popping up. It can be a challenge to keep up with reading all the papers you want to read. Other times it is cell biology news that keeps breaking. The big news of the past week or so was unfortunately the concerning development […]
Recommended reads: stem cells on the brain, heart, COVID Read More »
Somehow time has flown by so that I’ve been around for ages in the stem cell universe and some unproven stem cell clinic-type firms, like the well-known Panama stem cell clinic that sells autism “treatments”, are also long-timers. It’s been an odd parallel existence for more than a decade. Today’s post is focused on this
Fact-Checking Panama stem cell institute: cost, safety, efficacy, docs Read More »
Recently I was going through a list I’m updating of regenerative medicine biotech companies including Bluebird bio. Now just a few days later the world seems turned upside down for the firm and maybe to some degree for other companies doing related work. Bluebird bio blues: 2 trial participants get cancer News broke today that
Bluebird bio sickle cell gene therapy trial halted on cancer worry Read More »
There has been quite a lot of pubs on research on pluripotent stem cells published lately. These include some more surprising findings such as a potential role for pluripotency-related programming in neural crest development. Here the week’s recommended reads. Neural Crest research: ties to factors involved in pluripotent stem cells Science, Reactivation of the pluripotency
Recommended reads: pluripotent stem cells, neural crest, cancer, more Read More »
Science must go on and so must stem cell meetings 2021 with all those great conferences out there, but this year it’s going to be different, right? Every year I put up a continually-updated list of stem cell meetings and conferences. I’ve got my 2021 even if most of what’s out there is going to
Hub of Regenerative Medicine & Stem Cell Meetings 2021 Read More »
During the week as I’m doing other stuff I keep my eyes open for interesting things to read, including over the weekend about stem cell research, COVID, CRISPR, and more for The Niche weekly recommended reads. This week a lot was going as we updated The Niche site to our new theme and format. I
Recommended reads: jobs, FDA letter, & The Niche new look Read More »
When my wife and I were expecting our first daughter way back in the nineties, we received a paper pamphlet about cord blood banking. Back then, I was a graduate student at UC San Diego School of Medicine working toward my Ph.D. in Molecular Pathology and my wife was in medical school at the time
Fact-checking, pros and cons of cord blood banking Read More »
I’m playing catch-up on some reading given how busy I’ve been and this includes a groundbreaking NEJM pub on CRISPR for Sickle Cell and Thalassemia. CRISPR for Sickle Cell From December, here’s the key paper in the NEJM: CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. There’s a lot to like about this clinical
Recommended reads: CRISPR for Sickle Cell, Parkinson’s, & more Read More »
Sometimes on The Niche or while teaching students as a professor here at UC Davis School of Medicine, I’ve been asked: What is a teratoma? Not all tumors are created equal and some like teratomas are particularly unusual. Exactly what is a teratoma tumor? Teratomas are germ cell tumors. What this means is that the
What is a teratoma tumor? Research & treatment Read More »
The paper of the week reports using base-editing, a kind of gene-editing, to reverse mutations associated with rapid aging syndromes, generally called progeria, but there are a lot of other interesting pubs to recommend for reading this week. I go over it all in this post. Gene-editing to fight premature aging syndromes In vivo base
Weekly reads & paper of the week: gene-editing vs. aging Read More »